Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AbbVie
Company Monitoring Page for AbbVie
latest headlines for company on cafepharma
AbbVie in line for hefty payout after Takeda breached supply contract on Lupron
Fierce Pharma
Thu, 09/7/23 - 10:25 am
Tags:
AbbVie
,
Takeda
,
legal
,
Lupron
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Tags:
Medicare
,
HHS
,
Pfizer
,
Bristol Myers Squibb
,
Eli Lilly
,
Boehringer Ingelheim
,
AstraZeneca
,
AbbVie
,
Novo Nordisk
,
JNJ
,
drug pricing
AbbVie Removes Two Early-Stage Cancer Assets from Pipeline
BioSpace
Thu, 08/24/23 - 11:44 am
Tags:
AbbVie
,
antibody-drug conjugate
,
cancer
Why AbbVie’s former president has high hopes for this Flagship-backed biotech
Pharma Voice
Tue, 08/8/23 - 10:29 am
Tags:
Tessara Therapeutics
,
gene writing
,
AbbVie
,
Flagship Pioneering
,
Michael Severino
Amgen's hyped Humira biosimilar fritters away its exclusivity advantage
Fierce Pharma
Fri, 08/4/23 - 11:56 am
Tags:
Amgen
,
AbbVie
,
biosimilars
,
Humira
Despite big Q2 declines for Humira and Imbruvica, AbbVie still boosts earnings guidance
Fierce Pharma
Thu, 07/27/23 - 11:37 pm
Tags:
AbbVie
,
earnings
,
Humira
,
biosimilars
,
Imbruvica
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
Tags:
biosimilars
,
Humira
,
AbbVie
,
rebates
,
drug pricing
,
Amgen
,
Celltrion
,
Novartis
,
Boehringer Ingelheim
,
Biocon
,
Fresenius
,
Sandoz
,
Organon
,
Coherus
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
Wed, 07/26/23 - 11:37 am
Tags:
AbbVie
,
Skyrizi
,
Amgen
,
Otezla
,
Boehringer Ingelheim
,
psoriasis
Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment
Fierce Pharma
Mon, 07/24/23 - 09:35 pm
Tags:
Teva Pharmaceutical
,
Alvotech
,
biosimilars
,
Humira
,
AbbVie
,
drug manufacturing
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
Tags:
neurodegenerative disease
,
Alzheimer's disease
,
Axsome Therapeutics
,
Eli Lilly
,
Anavex
,
TauRx
,
AB Science
,
ALS
,
BrainStorm Cell Therapeutics
,
Seelos Therapeutics
,
Parkinson's Disease
,
AbbVie
,
Mitsubishi Tanabe Pharma
,
Annovis
,
Huntington's disease
,
Prilenia Therapeutics
,
Neurocrine
Check out the most-seen pharma brand TV debuts of 2023
Medical Marketing and Media
Wed, 07/19/23 - 05:49 pm
Tags:
TV ads
,
DTC advertising
,
Bayer
,
AbbVie
,
Bristol Myers Squibb
Four Crucial Questions about the Humira Biosimilar Price War
Drug Channels
Tue, 07/18/23 - 11:38 am
Tags:
AbbVie
,
Humira
,
biosimilars
AbbVie, Lilly-backed Capsida cuts staff months after signing Big Pharma deals
Fierce Biotech
Sun, 07/16/23 - 02:37 pm
Tags:
Capsida Biotherapeutics
,
layoffs
,
gene therapy
,
AbbVie
,
Eli Lilly
Gut punch: First Wave's challenger to AbbVie fails phase 2 again
Fierce Biotech
Thu, 07/13/23 - 10:18 am
Tags:
First Wave Biopharma
,
AbbVie
,
clinical trials
,
Creon
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
Tags:
AbbVie
,
Humira
,
biosimilars
,
Boehringer Ingelheim
,
Organon
,
Samsung Bioepsis
,
Sandoz
,
Fresenius Kabi
,
Celltrion
,
Coherus Biosciences
,
Biocon
Mark Cuban's online pharmacy set to launch Humira biosimilar
Reuters
Fri, 07/7/23 - 06:53 am
Tags:
biosimilars
,
Mark Cuban
,
Mark Cuban Cost Plus Drugs
,
AbbVie
,
Humira
,
Coherus Biosciences
Revance wants you to 'Break Up With Botox' as it goes to war with AbbVie in new anti-wrinkle market battle
Fierce Pharma
Mon, 07/3/23 - 10:44 am
Tags:
Revance Therapeutics
,
Daxxify
,
pharma marketing
,
AbbVie
,
Botox
Alvotech to raise cash after third FDA rejection for Humira biosimilar
BioPharma Dive
Fri, 06/30/23 - 11:39 am
Tags:
Alvotech
,
Teva Pharmaceutical
,
AbbVie
,
Humira
,
biosimilars
,
FDA
AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug
BioSpace
Thu, 06/29/23 - 11:15 pm
Tags:
AbbVie
,
Genmab
,
Roche
,
follicular lymphoma
,
bispecific antibodies
,
epcoritamab
,
Lunsumio
Genmab and AbbVie plan next steps for Epkinly in follicular lymphoma
Clinical Trials Arena
Wed, 06/28/23 - 10:27 am
Tags:
AbbVie
,
Genmab
,
Epkinly
,
clinical trials
,
relapsed or refractory follicular lymphoma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.